Psychiatric medication management for Lake Worth Beach — measurement-based, in-person.

Lake Worth Beach clients drive 22 minutes down A1A or I-95 to RECO Integrated Psychiatry's Delray office for outpatient medication management grounded in a documented DSM-5-TR formulation, visit-anchored PHQ-9 and GAD-7 scoring, and the full pharmacologic algorithm — augmentation with aripiprazole or lithium, cross-class switching, pharmacogenomic testing in complex cases, and appropriate escalation to rTMS or Spravato. Initial evaluations run 60 to 90 minutes. Monitoring labs and drug levels are built into the visit cadence rather than deferred to primary care.

Lake Worth Beach sits fourteen miles up A1A from RECO Integrated Psychiatry’s Delray campus — a 22-minute drive most of the year, longer through the January-to-March season. For adults living near Bryant Park, College Park, Mango Groves, Parrot Cove, or the downtown corridor, that distance is short enough to sustain weekly or biweekly medication follow-ups without disrupting work, school, or family routines. RECO’s outpatient psychiatric medication management service is built for that cadence: specialist-level pharmacotherapy on an outpatient schedule, grounded in DSM-5-TR formulation and measurement-based care.

What a real psychiatric evaluation actually covers

The initial evaluation at RECO runs 60 to 90 minutes and produces a documented DSM-5-TR diagnostic formulation — not a symptom checklist forwarded to a prescriber. History covers every prior medication trial by name, dose, duration, and the specific reason for discontinuation, whether that was inadequate response, intolerable side effects, adherence difficulty, or cost. Family psychiatric history is elicited across first- and second-degree relatives, and any presentation labeled “depression” or “anxiety” is screened for bipolarity (MDQ), ADHD (ASRS), and OCD (Y-BOCS) before a treatment plan is anchored to the presenting complaint.

Baseline labs are ordered where indicated: CBC, CMP, TSH, B12 and folate, vitamin D, and — for anyone with cardiovascular risk factors starting a stimulant or an SNRI — an ECG. A substance use screen with AUDIT and DAST is included in every intake, and trauma history is documented where clinically relevant to differential diagnosis. PTSD masquerading as treatment-resistant depression is common in this population; so is complex trauma driving what looks like emotionally unstable presentation. This is the evaluation primary care does not have the schedule to run and does not have the specialty training to formulate.

Measurement-based care and why it changes outcomes

Every RECO visit is anchored to structured outcome data. Depression is tracked with PHQ-9, anxiety with GAD-7, bipolar screening with MDQ, ADHD symptoms with the ASRS, and OCD with Y-BOCS — completed in the portal before the visit, scored during the visit, and trended in the chart over time. Medication decisions follow the trajectory of the score, not the answer to “how are you feeling today,” which is confounded by traffic on I-95, sleep the night before, and the weather that morning.

The published evidence for measurement-based care is unambiguous: patients whose treatment is anchored to serial scale scoring achieve remission at meaningfully higher rates than those managed on clinical impression alone. The reason is mechanical. A PHQ-9 that drops from 19 to 14 at six weeks is a partial response that calls for augmentation or dose optimization, not reassurance. A “somewhat better” verbal report at the same six-week mark tends to get accepted as good enough. RECO’s psychiatrists treat the scale trajectory as the primary datum and adjust accordingly.

The pharmacologic toolkit beyond the first two SSRIs

First-line pharmacotherapy is well established and often works. SSRIs — sertraline, escitalopram — and SNRIs — venlafaxine, duloxetine — for mood and anxiety. Stimulants (mixed amphetamine salts, methylphenidate) and non-stimulants (atomoxetine, guanfacine) for ADHD. Mood stabilizers (lithium, lamotrigine, valproate) and atypicals (quetiapine, aripiprazole, lurasidone) for bipolar disorder. SSRIs at OCD-range doses paired with an ERP therapy referral for OCD. Buspirone or hydroxyzine as non-benzodiazepine adjuncts for anxiety.

The value of specialty psychiatry is what happens after step two fails. RECO’s psychiatrists move through the treatment algorithm rather than rotating between two SSRIs for eighteen months. Augmentation strategies — aripiprazole 2 to 5 mg, lithium 300 to 900 mg, T3 thyroid augmentation — are used where indicated. Switching within class and across class (to bupropion, mirtazapine, or an MAOI in truly refractory presentations) remains on the table. Pharmacogenomic testing (GeneSight, Genomind) is offered in complex or treatment-resistant cases where CYP2D6 or CYP2C19 metabolism appears to be driving the pattern. Escalation to interventional treatment — rTMS or esketamine (Spravato) — is discussed at the point in the algorithm where the evidence supports it, not as a last resort after years of failed trials.

Monitoring: the labs, the metabolic panel, the drug levels

Prescribing without monitoring is not medication management. Lithium requires baseline and periodic TSH, creatinine, and calcium, plus lithium levels drawn twelve hours post-dose at initiation, after every dose change, and at least twice yearly at steady state. RECO targets 0.6 to 0.8 mEq/L for maintenance and 0.8 to 1.0 for acute mania, with dose held for values above 1.2. Atypical antipsychotics — quetiapine, olanzapine, aripiprazole, lurasidone — carry metabolic risk that requires baseline weight, waist circumference, fasting glucose or HbA1c, and lipid panel, repeated annually or sooner when weight change exceeds five percent.

Valproate requires baseline LFTs, CBC with platelets, and serum levels targeting 50 to 100 mcg/mL. Stimulants require documented cardiovascular history and blood pressure and heart rate at every visit, with appropriate caution in patients with structural heart disease or unexplained syncope. Clozapine, when used, is managed under the REMS ANC monitoring schedule. RECO’s visit cadence builds these intervals directly into the appointment calendar; nothing is deferred because the client did not think to ask, and lab results are reviewed inside the visit rather than acknowledged by portal message after the fact.

What to expect on your first visit

The intake appointment lasts 60 to 90 minutes and is conducted in person at the Delray Beach office. Clients complete PHQ-9, GAD-7, and any indicated additional screeners (MDQ, ASRS, Y-BOCS, AUDIT, DAST) in the portal the day before so the psychiatrist arrives with baseline data. Bring an itemized list of every psychiatric medication tried previously — name, highest dose, duration, and reason for discontinuation — and any relevant records from prior prescribers. Bring a current medication list including OTC supplements.

If controlled substances are being considered, the Florida E-FORCSE PDMP is checked at intake and at every subsequent visit. A written DSM-5-TR formulation and treatment plan are provided before the client leaves. Where clinically appropriate, the initial prescription is issued the same day; where more information is required — an outstanding lab, a records request from a prior psychiatrist, an ECG before a stimulant — the plan states that explicitly with a defined timeline.

Insurance and admissions from Lake Worth Beach

RECO Integrated Psychiatry is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS plans commonly held by Palm Beach County residents. Coverage is verified before the first appointment, and out-of-pocket cost — copay, coinsurance, remaining deductible — is quoted in writing rather than estimated at check-in. For Lake Worth Beach clients, the drive to Delray runs 22 minutes down I-95 or A1A outside of season; morning and late-afternoon slots are typically the least trafficked. After stabilization, follow-ups commonly transition from monthly to quarterly, and telepsychiatry follow-ups are available for established patients where clinically appropriate.

Serving residents of: Bryant Park, College Park, Mango Groves, Parrot Cove, downtown Lake Worth.